Alzai Health Corp. (TSXV:ALZI)
Canada · Delayed Price · Currency is CAD | Market Cap | 12.96M |
| Revenue (ttm) | 69.09K |
| Net Income | -4.13M |
| EPS | -0.08 |
| Shares Out | 64.80M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,000 |
| Open | 0.2000 |
| Previous Close | 0.2000 |
| Day's Range | 0.2000 - 0.2000 |
| 52-Week Range | 0.2000 - 0.5000 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 26, 2026 |
About Alzai Health
Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening. The company offers risk screening solutions for Mild Alzheimer’s Disease and Mild Cognitive Impairment. It caters to various markets including healthcare providers and payors, pharmaceutical companies, research organizations, and research sites, clinical trials and research companies, and public health and private payors. The company was incorporated in 2024 and is based in Toronto, Canada. [Read more]
Financial Performance
Financial StatementsNews
ALZAI Health Corp. Posted for Trading On The OTCQB Venture Market
Toronto, Ontario--(Newsfile Corp. - October 20, 2026) - ALZAI Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial inte...
ALZAI Health Corp. Posted for Trading on the Frankfurt Stock Exchange
Toronto, Ontario--(Newsfile Corp. - September 3, 2026) - ALZAI Health Corp. (TSXV: ALZI) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-drive...